Multitargeted CAR-T cells have been developed against HCC, and among them, Glypican-3 (GPC3), alpha-fetoprotein (AFP), c-MET, and Mucin 1 NKG2DL have been used as targets to develop CAR-T cells [101,102,103]. This evidence concerns the gene GPC3 and hepatocellular carcinoma.